Intellipharmaceutics Hit with Lawsuit for Allegedly Hyping Rexista By Sam | July 31, 2017 Intellipharmaceutics artificially inflated its stock prices during the NDA process for its oxycodone product Rexista, a new class-action lawsuit claims. Source: Drug Industry Daily Posted in Drug Industry Daily